Management of Limited-Stage Small Cell Lung Cancer (LS-SCLC)
Update: 2024-09-30
Description
In this episode, we dive into the latest survival data from the ADRIATIC trial, as presented at ASCO 2024, which could change the treatment landscape for LS-SCLC. Joining us are leading experts in oncology Zarnie Lwin, Susan Harden and Wei-Sen Lam.
Together, they explore the significance of the ADRIATIC trial results, debate the role of prophylactic cranial irradiation (PCI) in the treatment of SCLC, and provide insights into ongoing studies that may further improve outcomes for patients. Tune in for a deep dive into the latest research and expert perspectives on this aggressive cancer.
Podcasters:
Associate Professor Zarnie Lwin, OAM, Medical Oncologist at Royal Brisbane Women’s Hospital and the University of Queensland, QLD
Associate Professor Susan Harden, Radiation Oncologist at Peter MacCallum Cancer Centre and Monash Cancer Registries, VIC
Dr. Wei-Sen Lam, Medical Oncologist and TeleHealth lead at Fiona Stanley and Esperance Hospitals, WA
Together, they explore the significance of the ADRIATIC trial results, debate the role of prophylactic cranial irradiation (PCI) in the treatment of SCLC, and provide insights into ongoing studies that may further improve outcomes for patients. Tune in for a deep dive into the latest research and expert perspectives on this aggressive cancer.
Podcasters:
Associate Professor Zarnie Lwin, OAM, Medical Oncologist at Royal Brisbane Women’s Hospital and the University of Queensland, QLD
Associate Professor Susan Harden, Radiation Oncologist at Peter MacCallum Cancer Centre and Monash Cancer Registries, VIC
Dr. Wei-Sen Lam, Medical Oncologist and TeleHealth lead at Fiona Stanley and Esperance Hospitals, WA
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
